Michael Way
Molecular biology
Francis Crick Institute
United Kingdom
Biography
Michael Way did his undergraduate in the Biophysics Department at King's College, University of London. During his PhD he studied the actin binding properties of gelsolinin the laboratory of Alan Weeds in the structural studies division of the Medical Research Council Laboratory of Molecular Biology, Cambridge, UK. In 1989 he received the Max Perutz Student Prize for his PhD work. He remained in Alan's lab as a postdoc for three years studying the actin binding properties of alpha-actinin, dystrophin and gelsolin before moving to Boston, for a second three year postdoc with Paul Matsudaira at the Whitehead Institute, Massachusetts Institute of Technology, USA. In 1995, he moved back to Europe, starting his own group, studying vacciniavirus in the Cell Biology Programme at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany.
Research Interest
His current research focuses on variety of quantitative imaging and biochemical approaches to study how vaccinia virus takes advantage of its host as a model system to understand signalling networks, cytoplasmic transport and cytoskeletal dynamics.
Publications
-
Peddie, CJ; Domart, M-C; Snetkov, X; O'Toole, P; Larijani, B; Way, M; Cox, S and Collinson, LM (2017) Correlative super-resolution fluorescence and electron microscopy using conventional fluorescent proteins in vacuo. Journal of Structural Biology 199, 120-131
-
Durkin, CH; Leite, F; Cordeiro, JV; Handa, Y; Arakawa, Y; Valderrama, F and Way, M (2017) RhoD inhibits RhoC-ROCK-dependent cell contraction via PAK6. Developmental Cell 41, 315-329.e317
-
Ahmad, SA and Way, M (2017) New Editor on Journal of Cell Science. Journal of Cell Science 130, 303